📌 Key Takeaways
- Topic: Silicon Dioxide in Supplements: Purpose, Safety and Dosage Limits
- Keywords: INS 551
- Published: 2026-11-20 14:27:53
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Microsilica for Cement: Benefits, Dosage Guidelines and Applications
- Silica as a Desiccant: Moisture Capacity, Types and Uses
- What Is Highly Dispersible Silica (HDS)? Benefits for Tire Performance Explained
- Due to the essential function of MSNs in the biomedical field, the timeline of some key achievements involving MSNs is presented in Fig. 3. Comparable to MCM-41, Santa Barbara Amorphous-15 (SBA-15) is also demonstrated to be another really promising nanomaterial in the biomedical field, which is a highly stable mesoporous silica sieve reported by scientists from the University of California at Santa Barbara in 1998. 47 Several years later, the first instance of biomedical applications involving mesoporous silica for drug delivery is reported. 48 MCM-41 is revealed to have the talent to load and deliver the anti-inflammatory drug, ibuprofen, with a weight percent ratio of 30%. 48 In the same year, researchers from two different research groups both reported that the particle size of MCM-41 could be tuned to the nanoscale, 49, 50 and its morphology could also be precisely designed. 50 These findings have greatly encouraged researchers to discuss the potential biomedical applications of MSNs. In 2003, Lai et al. explored the feasibility of MCM-41-type MSNs in controlled-release delivery systems, in which they used cadmium sulfide (CdS) NPs as chemically removable caps to encapsulate drug molecules into the pore channels of MSNs. 51 Subsequently, the disulfide bond-reducing molecules served as triggers to control the stimuli-responsive release of drug molecules including vancomycin and adenosine triphosphate. 51 In the meantime, the same research group also utilized polyamidoamines to modify the surface of MCM-41-type MSNs, and constructed a novel gene transfection system in 2004, which is the first study of the uptake behavior about MSNs into the eukaryotic cells. 52 Afterwards, Lin et al. developed fluorescein-labelled hexagonal crystal-like MSNs with a size of 110 nm as cell marker. 53 To fully exploit the physicochemical properties of MSNs and their potential for biomedical applications, in 2008, Liong et al. loaded superparamagnetic iron oxide into the internal pores of MSNs and subjected MSNs to phosphonate coating, targeting ligand modification and anti-cancer drug encapsulation, resulting in a multifunctional silica-based nanoplatform that can be used for imaging, targeting and drug delivery. 54 Since the degradability of MSNs is critical to the growth of nanoformulations with high safety, researchers continue to discuss the degradation behavior and mechanisms of MSNs. In 2010, a three-state degradation process of MSNs was proposed, which presented a new understanding of the degradation kinetic mechanism of MSNs that differs markedly from that of traditional non-porous silica-based materials. 55 Apart from, Lin et al. systematically shown the impact of MSNs with diverse particle size, pore structure and surface modification on hemolytic activity in 2010. 56 This pioneering work delivers advice for understanding the toxic influences of MSNs in vivo. In 2011, Cornell dots, which are silica-based hybrid NPs with a size of 6-10 nm, become the first FDA-approved nanoformulation for a first-in-human clinical trial. 57 The first-in-human clinical trial of 124 I-labelled Cornell dots showed that they can be applied to diagnose and stage tumors including melanoma and malignant brain cancer. 58 Furthermore, to obtain MSNs with rapid biodegradability, Zhao's group developed a biphase stratification method for preparing monodispersed three-dimensional dendritic MSNs (3D-dendritic MSNs). The as-prepared 3D-dendritic MSNs can degrade completely in the simulated biological medium within 24 h. 59 Over the past few years, with the outbreak and spread of coronavirus SARS-CoV-2, nanotechnology based on MSNs against coronavirus infection has also developed. In 2020, Balagna et al. conducted preliminary antiviral test toward SARS-CoV-2 by using the silver nanocluster/silica nanocomposite deposited onto facial masks. 60 In another work, a FDA-approved antiviral drug, niclosamide (NIC), was encapsulated into MSNs, followed by the coating with Tween 60. The MSNs-based nanocomposite was demonstrated to be a potential oral formulation for SARS-CoV-2. 61
- Silica as a Thixotropic Agent: Mechanism, Dosage and Applications
- Silica for Sealants: Grades, Functions and Formulation Guide
Silica for Sunscreen: How It Improves Feel, Dispersion and SPF Performance
What is silica (SiO₂)?
silica supplier Vietnam
What is the difference between fumed silica and precipitated silica?
matting agent supplier
What drives silica raw material prices?
silica supplier Japan Firstly, even though several silica-based nanoformulations have already proceeded to the clinical trial stage and have been shown to be remarkably efficacious and acceptably secure, this is not virtually enough given the tremendous cost researchers have put in upfront. The most crucial consideration driving the successful clinical translation is a comprehensive and systematic toxicity study of MSNs. Despite the fact that a relatively finalize set of toxicity studies on MSNs has been established in the scientific community, a sustained effort is still needed. It is noteworthy that many of the currently designed therapeutic systems for MSNs are disconnected from systematic toxicological evaluations. Some researchers have focused more on the therapeutic impacts, but the feasible MSNs-based nanocomposites constructed on this basis are far from the silica NPs used by another part of the researchers in MSNs toxicology evaluation. In future research, under the premise of guaranteeing the efficacy of MSNs-based nanomedicines, more focus on the toxicological evaluation and long-term biosafety assessment of MSNs will be more useful to promote the possibility of their clinical translation.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.